1346674-23-4

Basic information

• Product Name: 3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one
• Synonyms: 3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one;7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one;4,4-DIMETHYL-1,10-DIAZATRICYCLO[6.4.0.0(2,6)]DODECA-2(6),7-DIEN-9-ONE(WX116139)
• CAS NO: 1346674-23-4
• Molecular Formula: C₁₂H₁₆N₂O
• Molecular Weight: 204.26824
• EINECS: -0
• Mol File: 1346674-23-4.mol

Chemical Properties

• Boiling Point: 456.4±44.0 °C(Predicted)
• Appearance: /
• Density: 1.30±0.1 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 14.82±0.40(Predicted)
• CAS DataBase Reference: 3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one(1346674-23-4)
• EPA Substance Registry System: 3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one(1346674-23-4)

Safety Data

• Hazardous Substances Data: 1346674-23-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one is used as a potential therapeutic agent for the treatment of neurological and psychiatric disorders due to its effects on the central nervous system.
Used in Oncology:
3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one is used as a potential enzyme inhibitor for the treatment of cancer, as it may have applications in inhibiting specific enzymes involved in cancer progression.
Used in Metabolic Disorders:
3,4,7,8-tetrahydro-7,7-dimethyl-2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one is used as a potential drug target for the treatment of metabolic disorders, indicating its potential role in managing or treating conditions related to metabolism.

Downstream Products

• 1433990-49-8 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}-4-fluorobenzaldehyde 
• 1433990-52-3 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾, 7-dien-10-yl}-4-fluoro-N-methylbenzamide 
• 1434050-55-1 4-chloro-2-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}pyridine-3-carbaldehyde 
• 1346676-30-9 2-(7,7-dimethyl-1-oxo-3,4,7,8-tetrahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2(6H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate 
• 1346674-24-5 2-bromo-6-(7,7-dimethyl-1-oxo-3,4,7,8-tetrahydro-1H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2(6H)-yl)benzyl acetate 
• 1346674-61-0 2-bromo-4-fluoro-6-(9-oxo-4,4-dimethyl-1,10diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl)benzyl acetate 
• 1433990-51-2 2-bromo-6-{4,4-dimethyl-9-oxo-1,10-diazatricyclo[6.4.0.0^2,6]dodeca-2⁽⁶⁾,7-dien-10-yl}-4-fluorobenzoic Acid 
• 1346670-16-3 10-[2-(hydroxymethyl)-3-[1-methyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridin-3-yl]phenyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.0(2,6)]dodeca-2⁽⁶⁾,7-dien-9-one 
• 1346674-25-6 10-[2-(acetoxymethyl)-3-[1-methyl-6-oxo-5-(pyrimidin-4-ylamino)-1,6-dihydropyridin-3-yl]phenyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.0(2,6)]dodeca-⁽⁶⁾,7-dien-9-one